FightSMA Blog | November 22, 2010
It’s not often that we get to see SMA researchers in their labs. That’s why the picture to the left is such a treat. It shows Dr. Brian Kaspar and one of his colleagues hard at work on gene therapy research that could some day yield a treatment or cure for spinal muscular atrophy. To get a better look, click on the image for a larger version.
Click HERE or on the image below to read more…
1 Comment | 
Blog post, FightSMA, Research | Tagged: blog post, fightsma, research | 
Permalink
Posted by stronwi
Royals Tour Motor Neuron Institute
Bedford Today | November 20, 2010
The Queen and Duke of Edinburgh have toured a £12 million motor neurone disease (MND) research centre in Sheffield.
Leave a Comment » | Research, United Kingdom | Tagged: research, united kingdom | Permalink
Posted by stronwi
Multiple Presentations on Spinal Muscular Atrophy at The 2010 Society for Neuroscience Meeting
FSMA Release | November 18, 2010
The 40th Annual Society of Neuroscience Meeting was held November 13 to 17, 2010 in San Diego, California. Over 31,000 neuroscientists were in attendance to hear about the latest developments in the field. The meeting included several dozen presentations on Spinal Muscular Atrophy.
About 30 presentations were given on SMA at the 2010 Society of Neuroscience Meeting, on both basic and drug development research. In the basic research area, talks were given by many of the leading labs in the field.
Leave a Comment » | FSMA, Press Release, Research | Tagged: FSMA, press release, research | Permalink
Posted by stronwi
FSMA Launches Next Phase of Drug Development Efforts for SMA
FSMA Release | November 11, 2010
Families of SMA (FSMA) announces Request for Proposals (RFP) for new drug programs to develop therapies for Spinal Muscular Atrophy. FSMA has made significant progress in advancing new therapies for SMA, starting with funding the first ever SMA drug program in 2000. The organization is now launching the next phase of therapeutic development work for SMA. FSMA is aiming to fund two new preclinical drug development programs in 2011, with more to follow. These multi-million dollar collaborations will focus on innovative methods of developing novel therapies for SMA, including both biologic and small molecule approaches. These programs will be multi-year in scope with a typical duration of three years. The requested proposals will be reviewed by the FSMA Translational Advisory Committee next spring.
1 Comment | FSMA, Press Release, Research | Tagged: FSMA, press release, research | Permalink
Posted by stronwi
SMAHeadlines.com 